Seeking Alpha
 

Eleven Biotherapeutics, Inc. (EBIO)

- NASDAQ
We currently have no Breaking News on this stock.
Visit Seeking Alpha's
EBIO vs. ETF Alternatives
Company Description
Eleven Biotherapeutics Inc is a clinical-stage biopharmaceutical company with a proprietary protein engineering platform, called AMP-Rx, that it applies to the discovery and development of protein therapeutics to treat diseases of the eye.
Sector: Healthcare
Industry: Biotechnology
Country: United States